Modig Berndt sold $80K of PHVS
Modig Berndt (Chief Executive Officer) sold 2,292 shares of Pharvaris N.V. (PHVS) at $34.77 on 2026-08-14 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Traders may monitor insider activity as a sentiment input, but without additional company-specific catalysts (earnings, trial results, guidance, deals), the incremental decision value is limited.
Market read
A disclosed CEO 10b5-1 sale is new information, but it is typically not a strong standalone catalyst.
What to watch
The article does not state whether other insiders sold, whether there were concurrent buys, or whether the company had any contemporaneous news that could contextualize the transaction.
Background
The article is an SEC Form 4 insider transaction disclosure for Pharvaris N.V., reporting a CEO open-market sale under a Rule 10b5-1 plan.
Ticker impact
Form 4 shows CEO Modig Berndt sold 2,292 shares of Pharvaris N.V. at $34.7669 on 2026-08-14 under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely short-lived and sentiment-driven.
The filing is a primary-source insider transaction, but it is explicitly under a pre-arranged 10b5-1 plan and the article provides no accompanying operational or financial catalyst.
Market effects
Minimal, as this is company-specific insider trading with no sector-wide regulatory or clinical update.
None indicated.
None indicated.
Counterpoint
10b5-1 sales are often mechanical and may not reflect bearish fundamentals; the sale could be for diversification or liquidity needs.
Key entities
- issuerPHVS
Pharvaris N.V., subject of the Form 4 insider sale disclosure.
- insiderModig Berndt
CEO and director who sold 2,292 shares under a pre-arranged 10b5-1 plan.
